Hair test for HIV treatment adherence
Part of Immune system & allergy, Infections clinical trials.
This study uses hair samples to see if they can tell if someone is taking their HIV medication regularly. If you've been on a stable HIV pill regimen for at least 6 months, this study may help improve monitoring for other patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HIV and have been on the same medication for at least 6 months.
- Your HIV pill contains emtricitabine or lamivudine.
- You are at least 18 and under 70 years old.
- You agree not to cut your hair shorter than 6 cm (about 2.5 inches) for 6 months.
- You agree to provide a small hair sample at the end of the study.
- You do not plan to dye, bleach, straighten, or chemically treat your hair for 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of medicine that aims to wake up HIV hiding in your body's cells by targeting a viral protein called Tat. The goal is to help find a way to clear the virus completely.
This study tests how well researchers can track HIV-related health and immune changes over time by collecting blood and other samples. It may help you and your care team by creating detailed monitoring, even if your HIV diagnosis is new or still being evaluated.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
This trial tests whether a simple urine test can help people living with HIV who have not yet achieved viral suppression. The test is done right at the clinic to quickly check if their HIV medication is being taken correctly, so their doctor can offer extra support.
This study tests whether people with HIV can safely collect small blood samples at home using finger-pricks and devices (“dried blood spots”). It may help make HIV monitoring easier and more convenient while on certain HIV medicines.
This early-stage study tests a new HIV medication (VH4524184) to understand how your body absorbs and processes it. You'll take a single dose of the medication with a small amount of radioactive tracer, which helps researchers track where the drug goes in your body.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.